Working… Menu
Trial record 1 of 4 for:    neflamapimod
Previous Study | Return to List | Next Study

Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03980938
Recruitment Status : Recruiting
First Posted : June 10, 2019
Last Update Posted : July 17, 2019
Voisin Consulting, Inc.
Information provided by (Responsible Party):
EIP Pharma Inc

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : July 2020